Pharmacological modulation of SERT transport activity influences a variety of neurophysiological processes, and inhibitors of SERT have been extensively used in the treatment of psychiatric diseases, such as depression and anxiety, with >30 drugs in current clinical use3. Here, SLC6A4 is linked to major depressive disorder.